MediWound MDWD
NASDAQ MDWD
$13.73 -0.11 (-0.79%)
As of: Sep 10, 2026 · 3:59 PM EDT

MediWound (MDWD) Price to Earnings (2014 - 2026)

MediWound (MDWD) posted Price to Earnings of 25.75 for Q2 2026, little changed on a QoQ basis from 25.86 in Q1 2026, and down 63.13% year-over-year from 69.85 in Q2 2025.

Analysis

MediWound (MDWD) Price to Earnings (2014 - 2026) Analysis & Trends

MediWound has reported Price to Earnings for 13 years, with the latest figure at 25.75 in Q2 2026.

  • On a quarterly basis, Price to Earnings fell 63.13% year-over-year to 25.75 in Q2 2026; TTM through Jun 2026 was 6.08, a 13.93% increase from a year earlier, with the FY2025 full-year figure at 10.06, down 57.7% from the prior year.
  • Price to Earnings was 25.75 for Q2 2026 at MediWound, roughly flat from 25.86 in the prior quarter.
  • The five-year high for Price to Earnings was 56.56 in Q2 2023, with the low at 62.4 in Q4 2023.
  • Average Price to Earnings over 5 years is 21.1, with a median of 23.98 recorded in 2023.
  • The largest YoY upside for Price to Earnings was 589.79% in 2023 against a maximum downside of 579.59% in 2023.
  • Over 5 years, Price to Earnings stood at 9.18 in 2022, then sank by 579.59% to 62.4 in 2023, then surged by 49.39% to 31.58 in 2024, then slumped by 42.57% to 45.03 in 2025, then jumped by 42.8% to 25.75 in 2026.
  • The last three Price to Earnings figures came in at 25.75 (Q2 2026), 25.86 (Q1 2026), and 45.03 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn
10 MediWound 156.09 Mn 120.75 Mn 337,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -25.75
Mar 31, 2026 -25.86
Dec 31, 2025 -45.03
Sep 30, 2025 -18.59
Jun 30, 2025 -15.79
Mar 31, 2025 -32.07
Dec 31, 2024 -31.58
Sep 30, 2024 -32.91
Jun 30, 2024 -22.69
Mar 31, 2024 -35.42
Dec 31, 2023 -62.40
Sep 30, 2023 -25.27
Jun 30, 2023 56.56
Mar 31, 2023 -18.04
Dec 31, 2022 -9.18
Sep 30, 2022 -9.05
Jun 30, 2022 -11.55
Mar 31, 2022 -15.16
Dec 31, 2021 -15.50
Sep 30, 2021 -27.26